STANDARD,
UNIVERSAL AND MASTER AGREEMENTS AND FORMS
These agreements are available as
starting points for negotiations with research sponsors, potential licensees,
and others, as the agreements will suggest by their nature. Faculty members
are welcomed to use these documents as starting points; however, all University
contracts must be processed through the appropriate office at each U. T. System
component institution.
- Includes:
- University Disclosing
- Mutual Confidentiality
- Created 3/6/00
- Includes:
- University Disclosing
- University Receiving
- Mutual
- Revised: 8/5/92
Industrial Research
Assistant Agreement (UTDAL)
- Status: created prior to 9/91;
no historical information available
Industrial Practica
Program Agreement
- Status: created prior to 9/91;
no historical information available
- Status: created 1/02 - OGC #09973
- Status: created 1/02 - OGC#09973
Materials Transfer
Agreement (UTMDACC Materials)
- Status: created prior to 9/91;
no historical information available
- Includes:
- University Disclosing
- University Receiving
- Mutual
- Revised: 8/5/92
- Revised 2/17/04
- Created 11/99 - OGC # 08925
Publishing: University
of Texas Press Agreements
- Standard Author Publishing Contract
- Variants for different purposes:
- Translator's Agreement
- Distribution Agreement
- Proprietor's Agreement
- Translation Agreement
- Copublication Agreement
- Reprint Agreement
- Illustrator's Agreement
- Miscellaneous other variant
agreements
- Permissions agreements
- Use UT Press Material with
Charge
- Use UT Press Material without
Charge
- Use in Dissertation
- Journals
- Agreement for Press-Owned
Journals
- Agreement for Society-Owned
Journals
- Distribution Agreements
- Consent to Publish Forms
- First Serial Rights Agreements
- Permissions Agreements
- Marketing
- Sales Agreement with Individual
Salespersons
- Sales Agreement with Sales
Organizations
- Sales Agreement for Representation
of University Publishers
- Status: created 1/02 - OGC #09973
- Status: created at component;
no historical information available
- Allocation of Rights in Intellectual Property and Rights to Carry-Out Follow-On Research, Development, or Commercialization
- Created: 03/04
- File No. 59833
Sponsored Clinical
Study Agreement (UTMDACC)
- Status: created prior to 9/91;
no historical information available
Sponsored Research
Agreement (UTMDACC)
- Status: created prior to 9/91;
no historical information available
Sponsored Research
Agreement - Long Form (UTEP)
- Status: created prior to 9/91;
no historical information available
Sponsored Research
Agreement -Short Form (UTEP)
- Status: created prior to 9/91;
no historical information available
Sponsored Research
Agreement (UTDAL)
- Status: created prior to 9/91;
no historical information available
Sponsored Research
Agreement (UTSA)
- Status: created prior to 9/91;
no historical information available
Transmittal
Forms
-
Includes:
-
-
Form
F/Software (For use with Conforming Software Agreements)
-
Form
L (For use with U.T. System License or Option Agreements)
-
Form
Q (For use with Conforming Clinical Trial Agreements)
These agreements are available as
starting points for negotiations with particular research sponsors for clinical,
and in some cases preclinical or other types of studies. Those highlighted
and underlined are linked to a copy of the document.
Faculty members are welcomed to use
these documents as starting points; however, all University contracts must be
processed through the appropriate office at each U. T. System component institution.
- Status: This agreement
was negotiated prior to 9/91; no historical information is available.
Abbott
Laboratories - Pharmaceuticals - Sponsored
Clinical Study Agreement
- Revised: 5/9/94
- File: 32907 (05200)
Abbott Laboratories - Master Clinical Study Agreement - Abbott Initiated
- Status: This agreement was fully executed on 12/7/06
- File: 63864
Adria
- Research Agreement
- Status: This agreement
was negotiated prior to 9/91; no historical information is available.
Amgen,
Inc. - Master Clinical Study Agreement for Phase I, II and III Studies Only
- Created: 12/27/00 (signed by UTMDACC,
UTHSCHOU, UTMB, UTSMCDAL, UTHCTY, UTHSCSA)
- File: 49818 (08828)
- Created: 2/1/06 (This agreement supersedes the earlier version dated 6/29/93)
- File: 56253
- Note: Please see Letter Agreement between University of Texas System and AstraZeneca, dated February 14, 2006.
Bayer -
Clinical Trial Agreement
- Created: 12/99
- File: 45216 (07862)
Biogen
- Material Transfer Agreement
- Revised: 6/24/94
- File: 33022 (05219)
- Revised: 7/13/95
- File: 37360 (06354)
Bristol-Myers Squibb
- Master Clinical Trial Agreement
- Created: 6/23/98
(signed by UTHSCSA, UTHSCHOU, UTMDACC, UTSMCDAL, UTMB, UTHCTY)
- Amended: Amendment
#1 effective 5/21/99; Amendment #2 effective 7/00; Amendment #3 effective
5/18/01
- File: 45751 (07953)
Burroughs Wellcome
- See Glaxo Wellcome
- Status: This agreement
was negotiated prior to 9/91; no historical information is available.
Ciba Geigy - Merged
with Sandoz to form Novartis - See Novartis
Dallas BioMedical
Corporation
- Status: This agreement was
negotiated prior to 9/91; no historical information is available.
DuPont Pharmaceuticals
Company - Master Clinical Trial Agreement
- Created: 7/00 (signed by
UTSMCDAL, UTHSCHOU, UTMB, UTHSCSA, UTMDACC, UTHCTY)
- File: 50590 (09045)
Eli
Lilly - Master Clinical Trial Agreement
- Created: 1/10/95
- Amended: Amendment #1 Effective
7/21/98; Amendment #2 Effective December 14, 1999; Amendment #3 Effective
3/25/02; Amendment #4 Effective December 12, 2003; Amendment #5 Effective 11/18/04.
- File: 24949 (03371)
- Created: 4/15/04
- File: 58045
Fujisawa
- Research and Study Agreement
- Status: This agreement was
negotiated prior to 9/91; no historical information is available.
Genderm
- Research Agreement
- Revised: 1/27/95
- File: 33827 (05437)
Genentech
- Clinical Research Agreement
- Status: This agreement was
negotiated prior to 9/91; no historical information is available.
Glaxo - See Glaxo Wellcome
- Created: November 10, 2003
- Amendment #1: April 6, 2005
-
- File: 57648
Glaxo
Wellcome, Inc. - Master Non-Clinical Research Agreement
- Note: This agreement is
between Glaxo Wellcome and UTMB only
- Created: 8/97
- File: 44108 (07687)
Glaxo
Wellcome, Inc. - Master Collaborative Research Agreement
- Created: 12/98 (signed by UTHSCHOU,
UTMDACC, UTMB, UTHSCSA, UTHCTY)
- Amended: Amendment #1 signed
8/99
- File: 45004 (07845)
Glaxo
Wellcome, Inc. - Master Clinical Research Agreement
- Created: 10/7/96 (signed
by UTSMCDAL, UTHSCHOU, UTMDACC, UTMB, UTHSCSA, UTHCTY)
- Revised: Amendment #1 signed 7/00
- File: 41511 (07209)
Hoffmann-La
Roche - Master Clinical Research Agreement
- Created: 5/1/96
- Amended: 8/24/98
- File: 29160 (04307)
Hoffmann-La
Roche - Preclinical Lab
Study Grant Agreement - Sponsor IND
Hoffmann-LaRoche
- Preclinical Lab Study Grant Agreement - Funded
Institutional IND
- File: 28656 (04171)
- Status: ICI merged with
Zeneca Pharmaceutical in mid-90's.
- Created: 8/04
- File: 59904
- Created: 1/05
- File: 58705
- Created: 4/95
- File: 36249 (06066)
Marion
Merrell Dow - Non-Governmental Clinical Study
Agreement
- Revised: 2/2/94
- File: 31308 (04882)
Matrix
- Clinical Research Agreement
- Status: This agreement was
negotiated prior to 9/91; no historical information is available.
Merck
& Co. - Clinical Study Agreement
- Revised: 6/15/95
- File: 28125 (04053)
NeoPharm,
Inc. - Master Clinical Trial Agreement for Sponsor-Initiated Studies Only
- Created: 12/02 (signed by
UTHSCSA, UTHSCHOU, UTSMCDAL, UTMDACC, UTMB, UTHCTY)
- File: 53086 (09744)
- Created: 9/1/98, effective
through 8/31/03 (signed by UTHSCSA, UTHSCHOU, UTSMCDAL, UTMDACC, UTMB, UTHCTY)
- File: 46423 (08087)
- Amended: Amendment #1 - (extends term: Effective 9/1/03 through 12/31/03)
- Created: Effective 1/1/04 through 12/31/08
- File 56990
- Amended: Amendment #1 - (Amended terms regarding Biological Samples)
- Revised: 6/14/95
- File: 36606 (06153)
Parke Davis - Warner
Lambert - See Warner Lambert
Pfizer
- Connecticut - Statement of Agreement - Clinical
Study
- File: 38201 (06541)
- Status: This agreement was
negotiated prior to 9/91; no historical information is available.
Pfizer
- New York - Clinical Study Agreement - Pfizer
Initiated Study
- Created 6/12/03 (signed by UTHSCSA,
UTHSCHOU, UTMDACC, UTHCTY, UTMB, UTSMCDAL)
- File: 54396
- Contact: The Office of Grants
& Contracts
- NOTE: Concept of Biological Samples
*not* included in this Master CSA. Contact OGC if your Pfizer Protocol includes
us sending
biological samples to Pfizer.
- Revised: 1/5/95
- File: 28940 (04243)
Pharmacyclics, Inc.
- Master Clinical Study Agreement
- Created: 3/9/01 (signed
by UTHSCHOU, UTMB, UTHCTY, UTSMCDAL, UTMDACC, UTHSCSA)
- File: 51939 (09419)
Purdue Pharma L.P.
- Master Clinical Study Agreement
- Created: 3/11/03 (signed
by UTHSCHOU, UTMB, UTHCTY, UTSMCDAL, UTMDACC, UTHSCSA)
- File: 55916
Quintiles,
Inc. - Master Clinical Trial Agreement
- Created: 4/98 (signed by
UTHSCHOU, UTMB, UTHCTY, UTSMCDAL, UTMDACC, UTHSCSA)
- File: 45581 (07924)
- Revised: 7/23/93
- File: 29937 (04513)
Roche Laboratories -
See Hoffman-La Roche
Roche Palo
Alto LLC (Syntex U.S.A. LLC) -
Master Clinical Research Agreement
- Created: 3/98 (signed by
UTHSCSA, UTHSCHOU, UTSMCDAL, UTMDACC, UTMB)
- Amended: Amendment #1 signed 7/03/03
added UTHCTY and UTAUS as parties, changed name from Syntex to Roche, other
sections changed or added relating to Record Retention and HIPAA
- File: 46335 (08077)
Sandoz
Pharmaceuticals - Merged with Ciba Geigy to
form Novartis - See Novartis
Schering Plough - Clinical Trial Research Agreement
- Revised: 3/4/96
- File: 29186 (04313)
Schering Plough Research Institute - Investigator Initiated Master Clinical Trial Research Agreement
- Created: 7/1/04
- File: 60152
Schering Plough Research Institute - Investigator Initiated Master Clinical Trial Research Agreement
- Note: This agreement is between Schering Plough and UTMDACC only
- Created: 1/99
- File: 51045 (09180)
Schering Plough Research Institute - Sponsored Protocol Master Clinical Trial Research Agreement
- Note: This agreement is between Schering Plough and UTMDACC only
- Created: late 1998
- File: 48021 (08405)
Searle & Company
- Master Clinical Trial Agreement
- Note: This agreement is
between Searle and UTMDACC only
- Created: 11/98
- File: 47116 (08218)
SmithKline
Beecham Pharmaceuticals - Division of SmithKline Beecham Corp. - Master Agreement
for Clinical Investigations
- Created: 6/12/96 (signed
by UTMDACC, UTHSCHOU, UTHSCSA, UTSMCDAL, UTMB)
- Amended: 8/97 and 11/98
for UTSMCDAL only; 3rd Amendment signed 3/00 adding UTHCTY as a party to the
Agreement
- File: 40326 (06979)
Syntex
U.S.A. LLC - See Roche Palo Alto LLC
- Created:
2/14/02
- File: 52074 (09454)
- Revised: 4/21/93
- File: 25999 (03570)
Upjohn
- Non-Governmental Clinical Study Agreement
- Revised: 10/5/93
- File: 30320 (04620)
Warner-Lambert Company - Non-Governmental Clinical Trial Agreement
- Revised: 8/98
- File: 30088 (04558)
- Created: 7/22/03
- File: 56170
- Effective August 2005, Wyeth is no longer honoring this Master MTA
- Created: 1/03
- File: 34649 (56171)
- Status: This agreement was
negotiated prior to 9/91; no historical information is available.
Zeneca Pharmaceuticals
- See AstraZeneca Pharmaceuticals LP
Intellectual
Property Section Home Page
University of Texas
System Office of General Counsel
Comments to intellectualproperty@utsystem.edu
Last updated:
February 12, 2007